Whole-exome sequencing identifies genetic markers for taxane-induced multi-organ adverse effects in breast cancer patients

Yamin Liu, Yamin Liu, Yunxiao Lin, Xueting Xing, Xueting Xing, Hai Zhang, Yongzhe Tang, Yongzhe Tang, Hao Wu, Shengying Qin, Ruizhuo Ouyang, Ruizhuo Ouyang, Cong Huai, Xiaoqing Zhang, Xiaoqing Zhang

Open source

DOI
10.3389/fphar.2026.1917835
Published
11
Container
Frontiers in Pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1917835,
  title = {Whole-exome sequencing identifies genetic markers for taxane-induced multi-organ adverse effects in breast cancer patients},
  author = {Yamin Liu and Yamin Liu and Yunxiao Lin and Xueting Xing and Xueting Xing and Hai Zhang and Yongzhe Tang and Yongzhe Tang and Hao Wu and Shengying Qin and Ruizhuo Ouyang and Ruizhuo Ouyang and Cong Huai and Xiaoqing Zhang and Xiaoqing Zhang},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1917835},
  url = {https://doi.org/10.3389/fphar.2026.1917835}
}

RIS

TY  - JOUR
TI  - Whole-exome sequencing identifies genetic markers for taxane-induced multi-organ adverse effects in breast cancer patients
AU  - Yamin Liu
AU  - Yamin Liu
AU  - Yunxiao Lin
AU  - Xueting Xing
AU  - Xueting Xing
AU  - Hai Zhang
AU  - Yongzhe Tang
AU  - Yongzhe Tang
AU  - Hao Wu
AU  - Shengying Qin
AU  - Ruizhuo Ouyang
AU  - Ruizhuo Ouyang
AU  - Cong Huai
AU  - Xiaoqing Zhang
AU  - Xiaoqing Zhang
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1917835
UR  - https://doi.org/10.3389/fphar.2026.1917835
ER  - 

APA

Liu, Y., Liu, Y., Lin, Y., Xing, X., Xing, X., Zhang, H., Tang, Y., Tang, Y., Wu, H., Qin, S., Ouyang, R., Ouyang, R., Huai, C., Zhang, X., & Zhang, X. (2026). Whole-exome sequencing identifies genetic markers for taxane-induced multi-organ adverse effects in breast cancer patients. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1917835

Source records